Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Tretinoin recalled?

Not under an active recall. Tretinoin was recalled 11 times in the past — all now closed. Most recent: Jun 14, 2022.

Most common reason: cGMP deviation (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Tretinoin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Tretinoin recalls in 2026

4 initiated in 2026, 11 in total — newest first
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA Inc NDC 0555-0808-02 D-1156-2022
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA NDC 0555-0808-02 D-0520-2022
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020
Class II · Moderate risk

Formula 82F

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1423-2020
Class II · Moderate risk

Tretinoin USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8033-2 D-0530-2018
Class II · Moderate risk

Tretinoin or All-Trans Retinoic Acid active pharmaceutical…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-942-2015